Potential implication of genetic polymorphisms and torque teno virus in sporadic breast cancer

Romanian Biotechnological Letters

Volumn 18, Issue 1, 2013, Pages 7889-7896

  Cimponeriu, Danut ^a   Ion, Daniela adriana ^b   Spandole, Sonia ^a   Apostol, Pompilia ^a   Toma, Mihai ^a   Radu, Irina ^a   Panduru, Nicolae ^b   Belc, Nastasia ^c   Berca, Lavinia Mariana ^c   Adascalului, Marian ^c   Niculae, Oana Mihaela ^c   Burcos, Traean ^d   Popa, Emil ^d   Popa, Ileana ^d   Stanilescu, Sorin ^d   Belusica, Laurentiu ^b   Cristian, Serafinceanu ^b  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Food And Bioresource Institute   (Romania)

^d The Coltea Bucharest Hospital   (Romania)

Author keywords

ACE id; AGTR1 a1166t; Enos 4ab; Sporadic breast cancer; TTV

Indexed keywords

TORQUE TENO VIRUS;

EID: 84876006552     PISSN: 12245984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. A. BROEKS, M.K. SCHMIDT, M.E. SHERMAN, F.J. COUCH, J.L. HOPPER, et al., Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum. Mol. Genet., 20(16):3289-3303 (2011).
2. D. HERR, M. RODEWALD, H.M. FRASER, G. HACK, R. KONRAD, R. KREIENBERG, C. WULFF, Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecol. Oncol., 109(3):418-425 (2008).
3. M. TAHMASEBI, S. BARKER, J.R. PUDDEFOOT, G.P. VINSON, Localisation of renin-angiotensin system (RAS) components in breast. Br. J. Cancer., 3; 95(1): 67-74 (2006).
4. G.M. TSE, F.C. WONG, A.K. TSANG, C.S. LEE, P.C. LUI, A.W. LO, B.K. LAW, R.A. SCOLYER, R.Z. KARIM, T.C. PUTTI, Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. J. Clin. Pathol., 58(6):600-604 (2005).
5. J.H. MARTIN, S. BEGUM, O. ALALAMI, A. HARRISON, K.W. SCOTT, Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol., 21(2):90-97 (2000).
6. M. VAKKALA, P. PAAKKO, Y. SOINI, eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int. J. Oncol., 17(4):6676-6671 (2000).
7. D. FUKUMURA, S. KASHIWAGI, R.K. JAIN, The role of nitric oxide in tumour progression. Nat. Rev. Cancer., 6(7):521-534 (2006).
8. S. LOIBL, G. VON MINCKWITZ, S. WEBER, H.P. SINN, V.B. SCHINI-KERTH, I. LOBYSHEVA, F. NEPVEU, G. WOLF, K. STREBHARDT, M. KAUFMANN, Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy. Cancer, 95(6):1191-1198 (2002).
9. E.C. CHINJE, I.J. STRATFORD, Role of nitric oxide in growth of solid tumours: a balancing act. Essays Biochem., 32:61-72 (1997).
10. DAVID F. KASHATUS AND CHRISTOPHER M. Counter. Chapter 2 A Role for eNOS in Oncogenic Ras-Driven Cancer, B. BONAVIDA (ed.), Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy (Cancer Drug Discovery and Development), Springer Science+Business Media, LLC, 2010, pp. 23-33.
11. K. MORTENSEN, S. HOLCK, I.J. CHRISTENSEN, J. SKOUV, D.M. HOUGAARD, J. BLOM, L.I. LARSSON, Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients. Clin. Cancer. Res., 5(5):1093-1097 (1999).
12. K.H. LIM, B.B. ANCRILE, D.F. KASHATUS, C.M. COUNTER, Tumour maintenance is mediated by eNOS. Nature, 452(7187):646-649 (2008).
13. M. ZICHE, L. MORBIDELLI, R. CHOUDHURI, H.T. ZHANG, S. DONNINI, H.J. GRANGER, Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factorinducedangiogenesis. J. Clin. Invest., 99: 2625-2634 (1997).
14. M.I. PHILLIPS, S. KAGIYAMA, Angiotensin II as a pro-inflammatory mediator. Curr. Opin. Investig. Drugs., 3(4):569-577 (2002).
15. P.N. SESHIAH, D.S. WEBER, P. ROCIC, L. VALPPU, Y. TANIYAMA, K.K. GRIENDLING, Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res., 91(5):406-413 (2002).
16. G. WOLF, F.N. ZIYADEH, U. HELMCHEN, G. ZAHNER, R. SCHROEDER, R.A. STAHL, Ang II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. Am J Physiol., 268(5 Pt 2):F940-947 (1995).
17. M. STOLL, S. MEFFERT, U. STROTH, T. UNGER, Growth or antigrowth: angiotensin and the endothelium. J. Hypertens., 13(12 Pt 2):1529-1534 (1995).
18. Y. TIAN, T. BALLA, A.J. BAUKAL, K.J. CATT, Growth responses to angiotensin II in bovine adrenal glomerulosa cells. Am. J. Physiol., 268(1 Pt 1):E135-144 (1995).
19. A. MUSCELLA, S. GRECO, M.G. ELIA, C. STORELLI, S. MARSIGLIANTE, Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J. Endocrinol., 173(2):315-323 (2002).
20. F. DESHAYES, C. NAHMIAS, Angiotensin receptors: a new role in cancer? Trends Endocrinol. Metab., 16(7):293-299 (2005).
21. M. FUJITA, I. HAYASHI, S. YAMASHINA, M. ITOMAN, M. MAJIMA, Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem. Biophys. Res. Commun., 294(2):441-447 (2002).
22. R. VAN DER KNAAP, C. SIEMES, J.W. COEBERGH, C.M. VAN DUIJN, A. HOFMAN, B.H. STRICKER, Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer, 112(4):748-757 (2008).
23. E. NAPOLEONE, A. CUTRONE, D. CUGINO, C. AMORE, A. DI SANTO, L. IACOVIELLO, G. DE GAETANO, M.B. DONATI, R. LORENZET, Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells. Thromb Res., 129(6):736-742 (2012).
24. A.F. LEVER, D.J. HOLE, C.R. GILLIS, I.R. MCCALLUM, G.T. MCINNES, P.L. MACKINNON, P.A. MEREDITH, L.S. MURRAY, J.L. REID, J.W. ROBERTSON, Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet, 352(9123):179-184 (1998).
25. R. LI, D. LYN, R. LAPU-BULA, A. ODUWOLE, P. IGHO-PEMU, B. LANKFORD, J. MORGAN, S. NKEMDECHI, G. LIU, C. PACK, N. SILVESTROV, D.A. VON DEUTSCH, Q. SONG, I.K. ABUKHALAF, E. OFILI, Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am J Hypertens., 17(7):560-567 (2004).
26. D. CRISAN, J. CARR, Angiotensin I-converting enzyme: genotype and disease associations. J. Mol. Diagn., 2(3):105-115 (2000).
27. B. RIGAT, C. HUBERT, F. ALHENC-GELAS, F. CAMBIEN, P. CORVOL, F. SOUBRIER, An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 86(4):1343-1346 (1990).
28. S. ZHONG, W. YEO, M. TANG, C. LIU, X.R. LIN, W.M. HO, P. HUI, P.J. JOHNSON, Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients. J. Med. Virol., 66:428-434 (2002).
29. M. BANDO, M. TAKAHASHI, S. OHNO, T. HOSONO, M. HIRONAKA, H. OKAMOTO, Y. SUGIYAMA, Torque teno virus DNA titre elevated in idiopathic pulmonary fibrosis with primary lung cancer. Respirology, 13:263-269 (2008).
30. E.M. DE VILLIERS, R. SCHMIDT, H. DELIUS, H. ZUR HAUSEN, Heterogeneity of TT virus related sequences isolated from human tumour biopsy specimens. J. Mol. Med., 80: 44-50 (2002).
31. H.K. BID, P.K. MANCHANDA, R. KONWAR, K. HANIF, V.L. NAYAK, V. SINGH, Does angiotensinconverting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia? Indian. J. Urol., 26(4):497-501 (2010).
32. F. DENG, Q. HU, B. TANG, F. HE, S. GUO, J. CHEN, F. LI, X. WU, J. ZHANG, H. ZHANG, J. ZHAO, H. ZHONG, L. HE, J. LI, L. ZHANG, S. WANG, Endothelial nitric oxide synthase gene intron 4, 27 bp repeat polymorphism and essential hypertension in the Kazakh Chinese population. Acta Biochim. Biophys. Sin. (Shanghai), 39(5):311-316 (2007).
33. H. REICH, J.A. DUNCAN, J. WEINSTEIN, D.C. CATTRAN, J.W. SCHOLEY, J.A. MILLER, Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney. Int., 63(4):1443-1449 (2003).
34. M. NINOMIYA, M. TAKAHASHI, T. NISHIZAWA, T. SHIMOSEGAWA, H. OKAMOTO, Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy. J. Clin. Microbiol., 46(2):507- 514 (2008).
35. K. LIU, S.V. MUSE, PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics, 21(9):2128-2129 (2005).
36. J.H. MOORE, Multifactor Dimensionality Reduction (MDR v.2.0.beta 8.4) [Computer program]. Downloaded at http://www.multifactordimensionalityreduction.org/.
37. Y.Y. SHI, L. HE, SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res., 15(2):97-98 (2005).
38. A. YAREN, S. TURGUT, R. KURSUNLUOGLU, I. OZTOP, G. TURGUT, C. KELTEN, E. ERDEM, Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J. Exp. Med., 210(2):109-116 (2006).
39. S. NAMAZI, A. MONABATI, S. ARDESHIR-ROUHANI-FARD, N. AZARPIRA, Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol. Carcinog., 49(12):1022- 1030 (2010).
40. C.A. HAIMAN, S.O. HENDERSON, P. BRETSKY, L.N. KOLONEL, B.E. HENDERSON, Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res., 63(20):6984-6987 (2003).
41. W.P. KOH, J.M. YUAN, C.L. SUN, D. VAN DEN BERG, A. SEOW, H.P. LEE, M.C. YU, Angiotensin Iconverting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res., 63(3):573-578 (2003).
42. W.P. KOH, J.M. YUAN, D. VAN DEN BERG, H.P. LEE, M.C. YU, Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis, 26(2):459-464 (2005).
43. J.M. YUAN, W.P. KOH, C.L. SUN, H.P. LEE, M.C. YU, Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis, 26(8):1389-1394 (2005).
44. S.A. ALVES CORRÊA, S.M. RIBEIRO DE NORONHA, N.C. NOGUEIRA-DE-SOUZA, C. VALLETA DE CARVALHO, A.M. MASSAD COSTA, J. JUVENAL LINHARES, M.T. VIEIRA GOMES, I.D. GUERREIRO DA SILVA, Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J. Renin Angiotensin Aldosterone Syst., 10(1):51-58 (2009).
45. A.M. GONZâLEZ-ZULOETA LADD, A. ARIAS VâSQUEZ, F.A. SAYED-TABATABAEI, J.W. COEBERGH, A. HOFMAN, O. NJAJOU, B. STRICKER, C. VAN DUIJN, Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 14(9):2143-2146 (2005).
46. E. ZINTZARAS, M. GRAMMATIKOU, G.D. KITSIOS, C. DOXANI, N. ZDOUKOPOULOS, C. PAPANDREOU, A. PATRIKIDOU, Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer: a genetic association study and meta-analysis. J. Hum. Genet., 55(11):743-748 (2010).
47. H. FU, Y. ZHANG, L. JIN, Z. DING, Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence. Breast Cancer Res. Treat., 128(2):595-598 (2011).
48. A.M. GHELANI, A. SAMANTA, A.C. JONES, S.S. MASTANA, Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis in South Asians and Caucasians of East Midlands in the United Kingdom. Rheumatol. Int., 31(10):1355-1361 (2011).
49. M. ZSOM, T. FüLöP, L. ZSOM, A. BARâTH, Z. MARóTI, E. ENDREFFY, Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients. Hemodial. Int., 15(4):501-508 (2011).
50. D. CONEN, R.J. GLYNN, J.E. BURING, P.M. RIDKER, R.Y. ZEE, Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study. J. Intern. Med., 263(4):376-385 (2008).
51. P.A. SâIZ, M.P. GARCíA-PORTILLA, B. PAREDES, C. ARANGO, B. MORALES, V. ALVAREZ, E. COTO, T. BASCARâN, M. BOUSOñO, J. BOBES, Lack of association between endothelial nitric oxide synthase (NOS3) gene polymorphisms and suicide attempts. Behav. Brain. Funct., 3:32 (2007).
52. H.H. SIGUSCH, R. SURBER, M.H. LEHMANN, S. SURBER, J. WEBER, A. HENKE, D. REINHARDT, A. HOFFMANN, H.R. FIGULLA, Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scand. J. Clin. Lab. Invest., 60(3):229-235 (2000).